Papers

3

Total Citations

112

H-Index

2

About

Martin M. Nentwich is a leading ophthalmologist and researcher specializing in the treatment of uveal melanoma, particularly through advanced robotic radiosurgery. His major contributions center on developing and validating frameless, image-guided robotic radiosurgery as a non-invasive alternative to traditional enucleation or plaque brachytherapy for medium and large uveal melanomas. His landmark 2015 study, cited 58 times, demonstrated the technique’s efficacy and high eye retention rate in 217 patients, establishing robotic radiosurgery as a viable organ-preserving treatment. Earlier, his 2008 paper (52 citations) pioneered a streamlined, 3-hour procedure under retrobulbar anesthesia, proving the feasibility and safety of this approach without patient immobilization. Nentwich’s work has significantly advanced ocular oncology, offering patients a precise, minimally invasive option that spares the eye while achieving local tumor control. His research has been instrumental in shifting clinical practice toward less invasive radiosurgical methods, with his cumulative citations reflecting the field’s recognition of his innovations in treating this rare but sight-threatening cancer.

Research Focus

Key Achievements

2
H-Index
3
Papers
112
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Robotic radiosurgery for the treatment of medium and large uveal melanoma
58 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Ludwig-Maximilians-Universität München, Augenklinik Heidelberg

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago